Oscar Health, Inc. financial data

Symbol
OSCR on NYSE
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 13 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 92% % -1.2%
Debt-to-equity 441% % 33%
Return On Equity -39% % -1785%
Return On Assets -7.3% % -1444%
Operating Margin -3.4% % -643%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $4,500,000,000 USD 45%
Weighted Average Number of Shares Outstanding, Basic 262,388,000 shares 9.2%
Weighted Average Number of Shares Outstanding, Diluted 262,388,000 shares -1.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $11,701,427,000 USD 28%
Revenue from Contract with Customer, Excluding Assessed Tax $28,593,000 USD 39%
General and Administrative Expense $28,892,000 USD -10%
Operating Income (Loss) $396,357,000 USD -792%
Nonoperating Income (Expense) $23,339,000 USD -22128%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $437,297,000 USD -1408%
Income Tax Expense (Benefit) $5,606,000 USD -23%
Net Income (Loss) Attributable to Parent $443,151,000 USD -1842%
Earnings Per Share, Basic -1.69 USD/shares -1636%
Earnings Per Share, Diluted -1.69 USD/shares -1790%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,774,151,000 USD 82%
Other Assets, Current $24,331,000 USD 14%
Assets, Current $4,613,404,000 USD 62%
Property, Plant and Equipment, Net $88,350,000 USD 32%
Operating Lease, Right-of-Use Asset $51,544,000 USD -9.8%
Other Assets, Noncurrent $119,719,000 USD 45%
Assets $6,325,411,000 USD 31%
Liabilities, Current $4,862,587,000 USD 40%
Operating Lease, Liability, Noncurrent $51,991,000 USD -14%
Other Liabilities, Noncurrent $51,994,000 USD -15%
Liabilities $5,344,676,000 USD 40%
Accumulated Other Comprehensive Income (Loss), Net of Tax $18,030,000 USD
Retained Earnings (Accumulated Deficit) $3,294,434,000 USD -16%
Stockholders' Equity Attributable to Parent $977,648,000 USD -3.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $980,735,000 USD -3.5%
Liabilities and Equity $6,325,411,000 USD 31%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $878,542,000 USD 38%
Net Cash Provided by (Used in) Financing Activities $4,873,000 USD -82%
Net Cash Provided by (Used in) Investing Activities $174,228,000 USD 42%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $709,187,000 USD 96%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,804,123,000 USD 81%
Interest Paid, Excluding Capitalized Interest, Operating Activities $154,000 USD -99%
Deferred Tax Assets, Valuation Allowance $696,298,000 USD 18%
Deferred Tax Assets, Gross $726,510,000 USD 20%
Operating Lease, Liability $68,707,000 USD -7.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $423,294,000 USD -1999%
Lessee, Operating Lease, Liability, to be Paid $89,418,000 USD -13%
Property, Plant and Equipment, Gross $229,992,000 USD 27%
Operating Lease, Liability, Current $16,716,000 USD 23%
Lessee, Operating Lease, Liability, to be Paid, Year Two $17,280,000 USD 5.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $16,716,000 USD 23%
Operating Lease, Weighted Average Discount Rate, Percent 0.106 pure -0.47%
Deferred Income Tax Expense (Benefit) $36,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $20,711,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year Three $17,267,000 USD 0.98%
Deferred Tax Assets, Operating Loss Carryforwards $624,221,000 USD 19%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $17,274,000 USD 0.62%
Additional Paid in Capital $4,256,972,000 USD 10%
Depreciation, Depletion and Amortization $6,730,000 USD -14%
Deferred Tax Assets, Net of Valuation Allowance $30,212,000 USD 114%
Interest Expense $24,369,000 USD -0.69%